Cargando…
Tolerability profile of bevacizumab in metastatic colorectal cancer: about a Medical Department experience
Colorectal cancer is one of the most common cancers worldwide, and associated with high mortality rates in our country. The prognosis of patients diagnosed with metastatic colorectal cancer (mCRC) has improved markedly over the last 12 years, increasing from 5 months with best supportive care to alm...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The African Field Epidemiology Network
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325501/ https://www.ncbi.nlm.nih.gov/pubmed/28292081 http://dx.doi.org/10.11604/pamj.2016.25.118.2266 |